ATE268904T1 - Zellbasiertes festphasentest - Google Patents

Zellbasiertes festphasentest

Info

Publication number
ATE268904T1
ATE268904T1 AT97911947T AT97911947T ATE268904T1 AT E268904 T1 ATE268904 T1 AT E268904T1 AT 97911947 T AT97911947 T AT 97911947T AT 97911947 T AT97911947 T AT 97911947T AT E268904 T1 ATE268904 T1 AT E268904T1
Authority
AT
Austria
Prior art keywords
cell
solid phase
need
based solid
phase test
Prior art date
Application number
AT97911947T
Other languages
English (en)
Inventor
Beverly Ann Brown
Patricia Ann Kasila
Original Assignee
Nen Life Science Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24993730&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE268904(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nen Life Science Prod Inc filed Critical Nen Life Science Prod Inc
Application granted granted Critical
Publication of ATE268904T1 publication Critical patent/ATE268904T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Silicon Compounds (AREA)
  • Fuel Cell (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT97911947T 1996-10-29 1997-10-29 Zellbasiertes festphasentest ATE268904T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/744,718 US5739001A (en) 1996-10-29 1996-10-29 Solid phase cell-based assay
PCT/US1997/019699 WO1998019163A1 (en) 1996-10-29 1997-10-29 A solid phase cell-based assay

Publications (1)

Publication Number Publication Date
ATE268904T1 true ATE268904T1 (de) 2004-06-15

Family

ID=24993730

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97911947T ATE268904T1 (de) 1996-10-29 1997-10-29 Zellbasiertes festphasentest

Country Status (5)

Country Link
US (1) US5739001A (de)
EP (1) EP0937250B1 (de)
AT (1) ATE268904T1 (de)
DE (1) DE69729469T2 (de)
WO (1) WO1998019163A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69831522T2 (de) 1997-03-03 2006-06-14 Amersham Biosciences Uk Ltd In-situ Zellextraktion und Assay-Verfahren
US20050227294A1 (en) * 1997-09-15 2005-10-13 Molecular Devices Corporation Molecular modification assays involving lipids
US7632651B2 (en) * 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US7745142B2 (en) * 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US20050089918A1 (en) * 1998-02-23 2005-04-28 Amersham Biosciences Uk Limited In-situ cell extraction and assay method
AU4701200A (en) * 1999-05-07 2000-11-21 Quantum Dot Corporation A method of detecting an analyte using semiconductor nanocrystals
US6686171B2 (en) 1999-05-10 2004-02-03 Tropix, Inc. Competitive chemiluminescent assay for cyclic nucleotide monophosphates
US6794156B2 (en) * 1999-05-10 2004-09-21 Applera Corporation Cell growth, induction and lysis in an antibody-coated microplate for use in an ELISA
US20030157586A1 (en) * 2002-02-21 2003-08-21 Martin Bonde Device and method for conducting cellular assays using multiple fluid flow
US7855074B2 (en) 2004-04-28 2010-12-21 Vaxdesign Corp. Artificial immune system: methods for making and use
US8030070B2 (en) * 2004-04-28 2011-10-04 Sanofi Pasteur Vaxdesign Corp. Artificial lymphoid tissue equivalent
US20070141552A1 (en) * 2004-04-28 2007-06-21 Warren William L Automatable artificial immune system (AIS)
US7785806B2 (en) * 2004-04-28 2010-08-31 Vaxdesign Corporation Method for determining the immunogenicity of an antigen
US8298824B2 (en) 2004-04-28 2012-10-30 Sanofi Pasteur Vaxdesign Corporation Methods of evaluating a test agent in a diseased cell model
US20060275270A1 (en) * 2004-04-28 2006-12-07 Warren William L In vitro mucosal tissue equivalent
US7709256B2 (en) * 2004-04-28 2010-05-04 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US8071373B2 (en) 2004-04-28 2011-12-06 Sanofi Pasteur Vaxdesign Corp. Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS)
US7771999B2 (en) * 2004-04-28 2010-08-10 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US7785883B2 (en) * 2004-04-28 2010-08-31 Vax Design Corp. Automatable artificial immune system (AIS)
US20070134685A1 (en) * 2005-09-06 2007-06-14 Invitrogen Corporation Control of chemical modification
ATE531793T1 (de) * 2005-12-21 2011-11-15 Sanofi Pasteur Vaxdesign Corp Eine poröse membran gerät, das die differenzierung von monozyten in dendritische zellen fördert
AU2006331504A1 (en) * 2005-12-21 2007-07-05 Vaxdesign Corporation In vitro germinal centers
EP2409714A1 (de) * 2006-06-27 2012-01-25 Sanofi Pasteur VaxDesign Corporation Modelle für die Bewertung von Impfstoffen
WO2009048661A1 (en) * 2007-07-16 2009-04-16 Vaxdesign Corporation Artificial tissue constructs comprising alveolar cells and methods for using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000252A (en) * 1974-01-04 1976-12-28 Kenneth Kosak Immunoscintillation cell
ES8501998A1 (es) * 1982-10-12 1984-12-16 Dynatech Lab Un recipiente que tiene al menos una cavidad o pocillo para contener al menos una muestra de ensayo durante una medicion fluometrica.
US4568649A (en) * 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
US4626513A (en) * 1983-11-10 1986-12-02 Massachusetts General Hospital Method and apparatus for ligand detection
JPS6111663A (ja) * 1984-06-28 1986-01-20 Ono Pharmaceut Co Ltd 酵素免疫測定法に用いられる酵素で標識されたロイコトリエン類
FR2615622B1 (fr) * 1987-05-19 1994-05-06 Ire Medgenix Sa Dosage plasmatique de monokines
SE8803602D0 (sv) * 1988-10-11 1988-10-11 Wallac Oy A sample plate with a plurality of sample wells or vials intended for radiolabeled binding assays
SE8804657D0 (sv) * 1988-12-27 1988-12-27 Gerald Potter Colin Support structure for use in a proximity assey
FR2679659B1 (fr) * 1991-07-23 1993-11-19 Medgenix Diagnostic Sa Procede de dosage in vitro de molecules au niveau de leur site de production par des cellules en culture et format technologique adapte.
ATE148234T1 (de) * 1991-10-01 1997-02-15 Weck Alain Ladislas De In vitro verfahren zur bestimmung in allergiediagnosen und weitere entzündungskrankheiten
DK0650396T3 (da) * 1993-05-17 1998-09-14 Amersham Int Plc Udstyr og fremgangsmåde til måling af celluære biokemiske processer.

Also Published As

Publication number Publication date
US5739001A (en) 1998-04-14
DE69729469D1 (de) 2004-07-15
WO1998019163A1 (en) 1998-05-07
EP0937250B1 (de) 2004-06-09
DE69729469T2 (de) 2005-06-09
EP0937250A1 (de) 1999-08-25

Similar Documents

Publication Publication Date Title
ATE268904T1 (de) Zellbasiertes festphasentest
DK496085D0 (da) Ruminddelt celledyrkningsindretning samt fremgangsmaade til dyrkning af celler
ES2157669T3 (es) Un dispositivo para realizar un ensayo, uso de una membrana en la fabricacion de dicho dispositivo, kit que comprende dicho dispositivo, y metodo para la deteccion de un analito usando dicho dispositivo.
DK0728207T3 (da) Telomeraseaktivitetsassays
GB2343248B (en) Optical measurement of fluid samples
CA2142868A1 (en) Chemical and microbiological test kit
ES2035317T3 (es) Un metodo para la deteccion y el analisis de celulas hematopoyeticas en una muestra.
BR0112385A (pt) Meio de coleta universal
ES2181871T3 (es) Inmunoensayo de numeracion celular.
MX9300494A (es) Metodo para la deteccion genetica de organismos, agentes infecciosos o componentes de una celula u organismo en una muestra biologica.
DE3782730D1 (de) Dichtungsstruktur fuer eine elektrochemische zelle.
DK614786A (da) Forseglingsmaerkat til en elektrokemisk metal-luft-celle
NO854448L (no) Sv40 ekspresjonsvektor inneholdende hbxag som en ekspresjonsmarkoer.
PT88615A (pt) Equipamento e metodo de dosagem imunometrica aplicavel a celulas completas
ATE227996T1 (de) Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod
DK1248852T3 (da) Fremgangsmåde til vurdering af levedygtigheden af en celle
Trainor Indicator algal assays: laboratory and field approaches
ATE329015T1 (de) Enzyme mit s-adenosyl-l-homocystein-hydrolase- ähnlicher aktivität.
SE9704935D0 (sv) Analysmetod med partiklar
ES8706966A1 (es) Metodo de ensayar muestras de fluido en cuanto a la presencia de anticuerpos contra un microorganismo y dispositivo correspondiente
DE59403729D1 (de) Testpflaster zur epicutanen hauttestung
ES2121756T3 (es) Analisis enzimatico y equipo de analisis para medir la activacion celular.
ATE253224T1 (de) Nachweis von zellen mittels spezifischer zellwand-bindender domänen (cbd) von zellwand-bindenden proteinen
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
WO2003058251A3 (en) Toxicity test

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties